Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating OverviewBusiness Wire • 05/08/24
Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 05/01/24
Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling ScholarshipBusiness Wire • 04/29/24
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024Business Wire • 04/24/24
Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health CanadaBusiness Wire • 04/22/24
Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual MeetingBusiness Wire • 04/17/24
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 04/05/24
Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceBusiness Wire • 04/01/24
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 04/01/24
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 03/22/24
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 03/20/24
IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 03/19/24
Evaluating Acadia's Market Position Following Pimavanserin's Clinical SetbackSeeking Alpha • 03/13/24
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 03/13/24
INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 03/12/24